Quality Improvement Program (QIP) to Reduce 30-Day Readmission in Malnourished Hospitalized Patients
Status: | Terminated |
---|---|
Conditions: | Food Studies |
Therapuetic Areas: | Pharmacology / Toxicology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | October 2014 |
End Date: | August 2015 |
Does a Rapid, Comprehensive Oral Nutritional Supplementation Quality Improvement Program (QIP) Reduce 30-Day Readmission in Malnourished Hospitalized Patients?
Newly admitted patients will be screened for risk of malnutrition. Patients will receive
either the feeding protocol or current oral nutrition supplement (ONS) practice, pending
location. Patients will continue the nutrition plan taking the supplement post discharge.
Study team will follow-up with telephone calls to help support post-discharge ONS
compliance. Quality and service utilization data will be gathered for analysis.
either the feeding protocol or current oral nutrition supplement (ONS) practice, pending
location. Patients will continue the nutrition plan taking the supplement post discharge.
Study team will follow-up with telephone calls to help support post-discharge ONS
compliance. Quality and service utilization data will be gathered for analysis.
Inclusion Criteria:
- Patient is ≥ 18 years of age.
- Patient is screened for malnutrition with an MST score ≥ 2 (see Appendix C).
- Patient has length of stay of hospital stay > 2 days.
- Patient is able to consume foods and beverages orally.
- Patient receives Ensure, Nepro or Glucerna during the course of his or her hospital
stay in connection with the QIP.
Exclusion Criteria:
- Patient is pregnant.
- Patient is intubated, receiving tube feeding or parenteral nutrition.
- Patient unable to provide HIPAA authorization and informed consent.
- Patient is discharged to hospice care.
- Patient has a condition that would preclude ingestion / absorption of the oral
nutritional supplements, including allergic response to any ONS ingredient.
- Patient has severe dementia or delirium, brain metastases, eating disorder, history
of significant neurological or psychiatric disorder.
- Patient has stated an allergy or intolerance to any of the ingredients in the study
products.
We found this trial at
4
sites
1775 West Dempster Street
Park Ridge, Illinois 60068
Park Ridge, Illinois 60068
(847) 723-2210
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Advocate Christ Medical Center Advocate Health Care, named among the nation
Click here to add this to my saved trials